New directions in poly(ADP-ribose) polymerase biology

FEBS Journal

Volumn 283, Issue 22, 2016, Pages 4017-4031

  Bock, Florian J ^a,b   Chang, Paul ^c  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Ribon Therapeutics   (United States)

Author keywords

ADP ribosylation; poly(ADP ribose) polymerases; post translational modification; stress response

Indexed keywords

BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE)RIBOSE BINDING PROTEIN; RNA; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE RIBOSE; ISOENZYME;

ADENOSINE DIPHOSPHATE RIBOSYLATION; BIOLOGICAL MODEL; BIOLOGY; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRESS; METABOLISM; POST TRANSCRIPTIONAL REGULATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; TRANSCRIPTION REGULATION; DNA REPAIR; GENETICS; HUMAN; MULTIGENE FAMILY; RNA PROCESSING;

ADENOSINE DIPHOSPHATE RIBOSE; CELL DIFFERENTIATION; DNA REPAIR; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; MULTIGENE FAMILY; POLY(ADP-RIBOSE) POLYMERASES; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84964632208     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13737     Document Type: Review

References (103)

1. Hottiger MO, Hassa PO, Lüscher B, Schüler H & Koch-Nolte F (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35, 208–219.
2. Gibson BA & Kraus LW (2012) New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13, 411–424.
3. Vyas S & Chang P (2014) New PARP targets for cancer therapy. Nat Rev Cancer 14, 502–509.
4. Drew Y (2015) The development of PARP inhibitors in ovarian cancer: from bench to bedside. Br J Cancer 113, S3–S9.
5. Vyas S, Chesarone-Cataldo M, Todorova T, Huang YH & Chang P (2013) A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. Nat Commun 4, 2240.
6. Bock FJ, Todorova TT & Chang P (2015) RNA regulation by poly(ADP-ribose) polymerases. Mol Cell 58, 959–969.
7. Masson M, Niedergang C, Schreiber V, Muller S, Murcia J & de Murcia G (1998) XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18, 3563–3571.
8. Iles N, Rulten S, El-Khamisy SF & Caldecott KW (2007) APLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaks. Mol Cell Biol 27, 3793–3803.
9. Ahel D, Hořejší Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP et al. (2009) Poly(ADP-ribose)–dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325, 1240–1243.
10. DaRosa PA, Wang Z, Jiang X, Pruneda JN, Cong F, Klevit RE & Xu W (2015) Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. Nature 517, 223–226.
11. Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM et al. (2015) A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066–1077.
12. Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grøfte M, Rask MB, Streicher W, Jungmichel S, Nielsen M et al. (2015) Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat Commun 6, 8088.
13. Leung AK (2014) Poly(ADP-ribose): an organizer of cellular architecture. J Cell Biol 205, 613–619.
14. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA & Chang P (2011) Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 42, 489–499.
15. Daniels CM, Ong SE & Leung AK (2015) The promise of proteomics for the study of ADP-ribosylation. Mol Cell 58, 911–924.
16. Feijs KL, Kleine H, Braczynski A, Forst AH, Herzog N, Verheugd P, Linzen U, Kremmer E & Lüscher B (2013) ARTD10 substrate identification on protein microarrays: regulation of GSK3β by mono-ADP-ribosylation. Cell Commun Signal 11, 5.
17. Troiani S, Lupi R, Perego R, Depaolini SR, Thieffine S, Bosotti R & Rusconi L (2011) Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays. FEBS J 278, 3676–3687.
18. Carter-O'Connell I, Jin H, Morgan RK, Zaja R, David LL, Ahel I & Cohen MS (2016) Identifying family-member-specific targets of mono-ARTDs by using a chemical genetics approach. Cell Rep 14, 621–631.
19. Vivelo CA & Leung AK (2015) Proteomics approaches to identify mono-(ADP-ribosyl)ated and poly(ADP-ribosyl)ated proteins. Proteomics 15, 203–217.
20. Rosenthal F & Hottiger MO (2014) Identification of ADP-ribosylated peptides and ADP-ribose acceptor sites. Front Biosci 19, 1041–1056.
21. Gagné JP, Isabelle M, Lo K, Bourassa S, Hendzel MJ, Dawson VL, Dawson TM & Poirier GG (2008) Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res 36, 6959–6976.
22. Daniels CM, Ong SE & Leung AK (2014) Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl)ation sites from cells. J Proteome Res 13, 3510–3522.
23. Jungmichel S, Rosenthal F, Altmeyer M, Lukas J, Hottiger MO & Nielsen ML (2013) Proteome-wide identification of poly(ADP-ribosyl)ation targets in different genotoxic stress responses. Mol Cell 52, 272–285.
24. Zhang Y, Wang J, Ding M & Yu Y (2013) Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome. Nat Methods 10, 981–984.
25. +) analog pairs. Curr Protoc Chem Biol 7, 121–139.
26. Roper SJ, Chrysanthou S, Senner CE, Sienerth A, Gnan S, Murray A, Masutani M, Latos P & Hemberger M (2014) ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells. Nucleic Acids Res 42, 8914–8927.
27. Gao F, Kwon S, Zhao Y & Jin Y (2009) PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 284, 22263–22273.
28. Hemberger M, Nozaki T, Winterhager E, Yamamoto H, Nakagama H, Kamada N, Suzuki H, Ohta T, Ohki M, Masutani M et al. (2003) Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev Biol 257, 371–381.
29. Cho SH, Goenka S, Henttinen T, Gudapati P, Reinikainen A, Eischen CM, Lahesmaa R & Boothby M (2009) PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood 113, 2416–2425.
30. Cho SH, Raybuck A, Wei M, Erickson J, Nam KT, Cox RG, Trochtenberg A, Thomas JW, Williams J & Boothby M (2013) B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase. J Immunol 191, 3169–3178.
31. Mehrotra P, Krishnamurthy P, Sun J, Goenka S & Kaplan MH (2015) Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development. Immunology 146, 537–546.
32. Riley JP, Kulkarni A, Mehrotra P, Koh B, Perumal NB, Kaplan MH & Goenka S (2013) PARP-14 binds specific DNA sequences to promote Th2 cell gene expression. PLoS One 8, e83127.
33. Mehrotra P, Riley JP, Patel R, Li F, Voss L & Goenka S (2011) PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation. J Biol Chem 286, 1767–1776.
34. Mehrotra P, Hollenbeck A, Riley JP, Li F, Patel RJ, Akhtar N & Goenka S (2013) Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates TH2 differentiation and allergic airway disease. J Allergy Clin Immunol 131, 521–531.
35. Nasta F, Laudisi F, Sambucci M, Rosado MM & Pioli C (2010) Increased Foxp3+ regulatory T cells in poly(ADP-ribose) polymerase-1 deficiency. J Immunol 184, 3470–3477.
36. Zhang P, Nakatsukasa H, Tu E, Kasagi S, Cui K, Ishikawa M, Konkel JE, Maruyama T, Wei G, Abbatiello B et al. (2013) PARP-1 regulates expression of TGF-β receptors in T cells. Blood 122, 2224–2232.
37. Luo X, Nie J, Wang S, Chen Z, Chen W, Li D, Hu H & Li B (2016) Poly(ADP-ribosyl)ation of FOXP3 protein mediated by PARP-1 regulates the function of regulatory T cells. J Biol Chem 291, 28675–28682.
38. Zhang P, Maruyama T, Konkel JE, Abbatiello B, Zamarron B, Wang Z & Chen W (2013) PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3. PLoS One 8, e71590.
39. Yélamos J, Monreal Y, Saenz L, Aguado E, Schreiber V, Mota R, Fuente T, Minguela A, Parrilla P, de Murcia G et al. (2006) PARP-2 deficiency affects the survival of CD4 + CD8+ double-positive thymocytes. EMBO J 25, 4350–4360.
40. Farrés J, Llacuna L, Martin-Caballero J, Martínez C, Lozano JJ, Ampurdanés C, López-Contreras AJ, Florensa L, Navarro J, Ottina E et al. (2015) PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors. Cell Death Differ 22, 1144–1157.
41. Bai P, Houten SM, Huber A, Schreiber V, Watanabe M, Kiss B, de Murcia G, Auwerx J & Murcia J (2007) Peroxisome proliferator-activated receptor (PPAR)-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/PPARγ heterodimer. J Biol Chem 282, 37738–37746.
42. Dantzer F, Mark M, Quenet D, Scherthan H, Huber A, Liebe B, Monaco L, Chicheportiche A, Sassone-Corsi P, de Murcia G et al. (2006) Poly(ADP-ribose) polymerase-2 contributes to the fidelity of male meiosis I and spermiogenesis. Proc Natl Acad Sci 103, 14854–14859.
43. Quénet D, Mark M, Govin J, van Dorsselear Schreiber V, Khochbin S & Dantzer F (2009) Parp2 is required for the differentiation of post-meiotic germ cells: identification of a spermatid-specific complex containing Parp1, Parp2, TP2 and HSPA2. Exp Cell Res 315, 2824–2834.
44. Marcon L & Boissonneault G (2004) Transient DNA strand breaks during mouse and human spermiogenesis: new insights in stage specificity and link to chromatin remodeling. Biol Reprod 70, 910–918.
45. Todorova T, Bock FJ & Chang P (2014) PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript. Nat Commun 5, 5362.
46. Todorova T, Bock FJ & Chang P (2015) Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. Trends Mol Med 21, 373–384.
47. Iqbal BM, Johns M, Cao J, Liu Y, Yu SC, Hyde GD, Laffan MA, Marchese FP, Cho S, Clark AR et al. (2014) PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression. Blood 124, 3646–3655.
48. LeBlanc HN & Ashkenazi A (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10, 66–75.
49. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407, 258–264.
50. Darnell RB (2010) HITS-CLIP: panoramic views of protein–RNA regulation in living cells. Wiley Interdiscip Rev RNA 1, 266–286.
51. Bai P, Nagy L, Fodor T, Liaudet L & Pacher P (2015) Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol Metab 26, 75–83.
52. Iansante V, Choy PM, Fung SW, Liu Y, Chai JGG, Dyson J, Del Rio A, D'Santos C, Williams R, Chokshi S et al. (2015) PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nat Commun 6, 7882.
53. Formentini L, Macchiarulo A, Cipriani G, Camaioni E, Rapizzi E, Pellicciari R, Moroni F & Chiarugi A (2009) Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure. J Biol Chem 284, 17668–17676.
54. Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, Poirier GG, Dawson VL & Dawson TM (2014) Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci 111, 10209–10214.
55. Fouquerel E, Goellner EM, Yu Z, Gagné JP, Barbi de Moura M, Feinstein T, Wheeler D, Redpath P, Li J, Romero G et al. (2014) ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion. Cell Rep 8, 1819–1831.
56. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446.
57. Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino P, Pequignot MO, Casares N, Lazar V et al. (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23, 4679–4689.
58. Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH et al. (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13, 461–468.
59. Bai P, Canto C, Brunyánszki A, Huber A, Szántó M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H et al. (2011) PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13, 450–460.
60. Pirinen E, Cantó C, Jo Y, Morato L, Zhang H, Menzies KJ, Williams EG, Mouchiroud L, Moullan N, Hagberg C et al. (2014) Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 19, 1034–1041.
61. De Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, Dantzer F, Schreiber V, Amé JC, Dierich A, LeMeur M et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22, 2255–2263.
62. Chiang J, Hsiao S, Yver D, Cushman S, Tessarollo L, Smith S & Hodes R (2008) Tankyrase 1 and Tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One 3, e2639.
63. Meyer-Ficca ML, Ihara M, Bader JJ, Leu AN, Beneke S & Meyer RG (2015) Spermatid head elongation with normal nuclear shaping requires ADP-ribosyltransferase PARP11 (ARTD11) in mice. Biol Reprod 92, 1–13.
64. Beck C, Robert I, Reina-San-Martin B, Schreiber V & Dantzer F (2014) Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3. Exp Cell Res 329, 18–25.
65. Li M & Yu X (2015) The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy. Oncogene 34, 3349–3356.
66. Walter P & Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081–1086.
67. Jwa M & Chang P (2012) PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. Nat Cell Biol 14, 1223–1230.
68. Petesch SJ & Lis JT (2012) Activator-induced spread of poly(ADP-ribose) polymerase promotes nucleosome loss at Hsp70. Mol Cell 45, 64–74.
69. Di Giammartino D, Shi Y & Manley JL (2013) PARP1 represses PAP and inhibits polyadenylation during heat shock. Mol Cell 49, 7–17.
70. Thedieck K, Holzwarth B, Prentzell M, Boehlke C, Kläsener K, Ruf S, Sonntag A, Maerz L, Grellscheid SN, Kremmer E et al. (2013) Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. Cell 155, 964–966.
71. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H & Takekawa M (2008) Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol 10, 1324–1332.
72. Vyas S, Matic I, Uchima L, Rood J, Zaja R, Hay RT, Ahel I & Chang P (2014) Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat Commun 5, 4426.
73. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH & Borden EC (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8, 237–249.
74. Seo G, Kincaid RP, Phanaksri T, Burke JM, Pare JM, Cox JE, Hsiang TY, Krug RM & Sullivan CS (2013) Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14, 435–445.
75. Karin M & Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749–759.
76. Erener S, Pétrilli V, Kassner I, Minotti R, Castillo R, Santoro R, Hassa PO, Tschopp J & Hottiger MO (2012) Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-κB target genes. Mol Cell 46, 200–211.
77. Minotti R, Andersson A & Hottiger MO (2015) ARTD1 suppresses interleukin 6 expression by repressing MLL1-dependent histone H3 trimethylation. Mol Cell Biol 35, 3189–3199.
78. Verheugd P, Forst AH, Milke L, Herzog N, Feijs K, Kremmer E, Kleine H & Lüscher B (2013) Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat Commun 4, 1683.
79. Herzog N, Hartkamp JD, Verheugd P, Treude F, Forst AH, Feijs KLH, Lippok BE, Kremmer E, Kleine H & Lüscher B (2013) Caspase-dependent cleavage of the mono-ADP-ribosyltransferase ARTD10 interferes with its pro-apoptotic function. FEBS J 280, 1330–1343.
80. Peterson FC, Chen D, Lytle BL, Rossi MN, Ahel I, Denu JM & Volkman BF (2011) Orphan macrodomain protein (human C6orf130) is an O-acyl-ADP-ribose deacylase SOLUTION STRUCTURE AND CATALYTIC PROPERTIES. J Biol Chem 286, 35955–35965.
81. Jankevicius G, Hassler M, Golia B, Rybin V, Zacharias M, Timinszky G & Ladurner AG (2013) A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat Struct Mol Biol 20, 508–514.
82. Rosenthal F, Feijs KL, Frugier E, Bonalli M, Forst AH, Imhof R, Winkler HC, Fischer D, Caflisch A, Hassa PO et al. (2013) Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat Struct Mol Biol 20, 502–507.
83. Teloni F & Altmeyer M (2016) Readers of poly(ADP-ribose): designed to be fit for purpose. Nucleic Acids Res 44, 993–1006.
84. Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D & Ahel I (2011) The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477, 616–620.
85. Neuvonen M & Ahola T (2009) Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J Mol Biol 385, 212–225.
86. Sharifi R, Morra R, Appel DC, Tallis M, Chioza B, Jankevicius G, Simpson MA, Matic I, Ozkan E, Golia B et al. (2013) Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J 32, 1225–1237.
87. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL & Jacobson MK (2004) Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp Cell Res 297, 521–532.
88. Ohashi S, Kanai M, Hanai S, Uchiumi F, Maruta H, Tanuma S & Miwa M (2003) Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cells. Biochem Biophys Res Commun 307, 915–921.
89. Barkauskaite E, Brassington A, Tan ES, Warwicker J, Dunstan MS, Banos B, Lafite P, Ahel M, Mitchison TJ, Ahel I et al. (2013) Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities. Nat Commun 4, 2164.
90. Jenuwein T & Allis DC (2001) Translating the histone code. Science 293, 1074–1080.
91. Feijs KL, Forst AH, Verheugd P & Lüscher B (2013) Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation. Nat Rev Mol Cell Biol 14, 443–451.
92. Callow MG, Tran H, Phu L, Lau T, Lee J, Sandoval WN, Liu PS, Bheddah S, Tao J, Lill JR et al. (2011) Ubiquitin ligase RNF146 regulates tankyrase and axin to promote Wnt signaling. PLoS One 6, e22595.
93. Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, Schirle M, Shi X, Hild M, Bauer A et al. (2011) RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13, 623–629.
94. Chang W, Dynek JN & Smith S (2005) NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem J 391, 177–184.
95. Li N, Zhang Y, Han X, Liang K, Wang J, Feng L, Wang W, Songyang Z, Lin C, Yang L et al. (2014) Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth. Genes Dev 29, 157–170.
96. Wang W, Li N, Li X, Tran M, Han X & Chen J (2015) Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins. Cell Rep 13, 524–532.
97. Levaot N, Voytyuk O, Dimitriou I, Sircoulomb F, Chandrakumar A, Deckert M, Krzyzanowski P, Scotter A, Gu S, Janmohamed S et al. (2011) Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell 147, 1324–1339.
98. Wang Z, Michaud GA, Cheng Z, Zhang Y, Hinds TR, Fan E, Cong F & Xu W (2012) Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination. Genes Dev 26, 235–240.
99. Guettler S, LaRose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R & Sicheri F (2011) Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease. Cell 147, 1340–1354.
100. Bredehorst R, Ferro AM & Hilz H (1978) Production of antibodies against ADP-ribose and 5′-AMP with the aid of N6-carboxymethylated ADP-ribose conjugates. Eur J Biochem 82, 105–113.
101. Kistemaker HA, Lameijer LN, Meeuwenoord NJ, Overkleeft HS, van der Marel GA & Filippov DV (2015) Synthesis of well-defined adenosine diphosphate ribose oligomers. Angew Chem Int Ed Engl 54, 4915–4918.
102. Lambrecht MJ, Brichacek M, Barkauskaite E, Ariza A, Ahel I & Hergenrother PJ (2015) Synthesis of dimeric ADP-ribose and its structure with human poly(ADP-ribose) glycohydrolase. J Am Chem Soc 137, 3558–3564.
103. Moyle PM & Muir TW (2010) Method for the synthesis of mono-ADP-ribose conjugated peptides. J Am Chem Soc 132, 15878–15880.